Follow the 바이오인프라생명과학 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 바이오인프라생명과학 has published 12 insider filings. The latest transaction was reported on 16 December 2024 (Purchase). Among the most active insiders: 이정호. Every trade is accessible without an account.
12
Insider Decl.
n/a
Thresholds
n/a
10 ops.
Buy Volume
n/a
2 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.